This inventor holds 2 USPTO granted patents. Top assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2013-2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013-2014
Title: Congxiao Zhang: Innovator in Therapeutic Applications of miR Technologies
Introduction
Congxiao Zhang is a notable inventor based in Rockville, MD (US). He has made significant contributions to the field of therapeutic applications, particularly focusing on microRNAs and their potential in treating various medical conditions. With a total of 2 patents, his work is paving the way for innovative treatments in healthcare.
Latest Patents
Zhang's latest patents include advancements related to miR 204 and miR 211, along with their anti-miRs. These patents detail methods for preventing or treating detrimental epithelial cell proliferation, loss of epithelial cell differentiation, age-related macular degeneration, and proliferative vitreal retinopathy. The embodiments of his inventions provide methods for administering effective amounts of miR 204, miR 211, or a mixture of both to individuals in need. Additionally, his patents include methods for facilitating the transport of substances across epithelial barriers using anti-miR 204 and anti-miR 211.
Career Highlights
Congxiao Zhang is associated with the United States of America, as represented by the Secretary, Department of Health and Human Services. His work is instrumental in advancing therapeutic strategies that leverage the unique properties of microRNAs.
Collaborations
Zhang has collaborated with notable colleagues, including Fei Wang and Sheldon S Miller, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Congxiao Zhang's contributions to the field of microRNA therapeutics highlight his role as a leading inventor in medical innovation. His patents reflect a commitment to improving health outcomes through advanced scientific research and collaboration.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile